| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1033665645 |
| P356 | DOI | 10.1007/S11010-016-2735-9 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s11010-016-2735-9 |
| P698 | PubMed publication ID | 27334756 |
| P50 | author | Thomas S Weiss | Q39813494 |
| Gerhard Liebisch | Q42705098 | ||
| Andrew J. Hoy | Q47504400 | ||
| Thomas Grewal | Q61305309 | ||
| Christa Buechler | Q87732211 | ||
| P2093 | author name string | Kristina Eisinger | |
| Lisa Rein-Fischboeck | |||
| Rebekka Pohl | |||
| Sabrina Krautbauer | |||
| Josef Wanninger | |||
| Elisabeth M Meier | |||
| P2860 | cites work | NIH Image to ImageJ: 25 years of image analysis | Q23319322 |
| Free fatty acids, lipopolysaccharide and IL-1α induce adipocyte manganese superoxide dismutase which is increased in visceral adipose tissues of obese rodents | Q27329108 | ||
| Annexin expressions are temporally and spatially regulated during rat hepatocyte differentiation | Q28570379 | ||
| Interactions between metabolism and intracellular distribution of cholesterol and sphingomyelin | Q33889087 | ||
| Annexin A6-induced alterations in cholesterol transport and caveolin export from the Golgi complex | Q34412267 | ||
| Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin release | Q34656848 | ||
| The autophagy-related marker LC3 can predict prognosis in human hepatocellular carcinoma | Q35055351 | ||
| Adiponectin, a key adipokine in obesity related liver diseases | Q35061908 | ||
| Cholesterol transport from late endosomes to the Golgi regulates t-SNARE trafficking, assembly, and function. | Q35475076 | ||
| Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis | Q35810018 | ||
| Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis | Q35939383 | ||
| Role of annexin A6 in cancer | Q36085446 | ||
| The epidemiology of nonalcoholic fatty liver disease in adults | Q36422726 | ||
| A dynamic plasma membrane proteome analysis of alcohol-induced liver cirrhosis | Q36571861 | ||
| Annexin A6 is down-regulated through promoter methylation in gastric cancer | Q37099917 | ||
| Annexin A6 is highly abundant in monocytes of obese and type 2 diabetic individuals and is downregulated by adiponectin in vitro | Q37290031 | ||
| A specific cholesterol metabolic pathway is established in a subset of HCCs for tumor growth. | Q37344324 | ||
| Annexins--modulators of EGF receptor signalling and trafficking | Q37454668 | ||
| Reduced annexin A6 expression promotes the degradation of activated epidermal growth factor receptor and sensitizes invasive breast cancer cells to EGFR-targeted tyrosine kinase inhibitors | Q37581161 | ||
| Annexin A6-regulator of the EGFR/Ras signalling pathway and cholesterol homeostasis | Q37665617 | ||
| The role of cytokines in non-alcoholic fatty liver disease | Q37749330 | ||
| Animal models of non-alcoholic steatohepatitis: of mice and man. | Q37749366 | ||
| Annexin A6-Linking Ca(2+) signaling with cholesterol transport. | Q37796184 | ||
| Biological functions of sphingomyelins | Q38107705 | ||
| The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis | Q38169563 | ||
| Lysosomal cholesterol accumulation: driver on the road to inflammation during atherosclerosis and non-alcoholic steatohepatitis | Q38195943 | ||
| Free fatty acids and IL-6 induce adipocyte galectin-3 which is increased in white and brown adipose tissues of obese mice | Q38305642 | ||
| Manganese superoxide dismutase is reduced in the liver of male but not female humans and rodents with non-alcoholic fatty liver disease | Q38311635 | ||
| Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver | Q38313704 | ||
| Lipidomic analysis of serum from high fat diet induced obese mice | Q38345748 | ||
| Annexin A6 and Late Endosomal Cholesterol Modulate Integrin Recycling and Cell Migration. | Q38818776 | ||
| Genome-wide transcriptional profiling analysis reveals annexin A6 as a novel EZH2 target gene involving gastric cellular proliferation | Q38878459 | ||
| Annexin A6 is a scaffold for PKCα to promote EGFR inactivation | Q39314490 | ||
| Shorthand notation for lipid structures derived from mass spectrometry. | Q40470345 | ||
| Human parenchymal and non-parenchymal liver cell isolation, culture and characterization | Q40706779 | ||
| Studies on the biosynthesis of polyisoprenols, cholesterol and ubiquinone in highly differentiated human hepatomas | Q41149296 | ||
| Evidence for the Involvement of annexin 6 in the trafficking between the endocytic compartment and lysosomes | Q43721897 | ||
| Cholesterol modulates the membrane binding and intracellular distribution of annexin 6. | Q44031840 | ||
| High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm | Q45136777 | ||
| Inhibition of DNA-dependent protein kinase reduced palmitate and oleate-induced lipid accumulation in HepG2 cells. | Q45991426 | ||
| Lipidomic analysis of the liver from high-fat diet induced obese mice identifies changes in multiple lipid classes. | Q46027494 | ||
| MMP-9 activity is increased by adiponectin in primary human hepatocytes but even negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis | Q46858826 | ||
| High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS/MS). | Q46928125 | ||
| Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. 1999. | Q48396083 | ||
| A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. | Q50115050 | ||
| Intrahepatic IL-8 producing Foxp3⁺CD4⁺ regulatory T cells and fibrogenesis in chronic hepatitis C. | Q51036191 | ||
| Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice. | Q51475764 | ||
| Annexin A6 inhibits Ras signalling in breast cancer cells. | Q51785771 | ||
| Characterization and immunolocalization of rat liver annexin VI. | Q52871587 | ||
| Adipocytokines and hepatocellular carcinoma. | Q53262794 | ||
| Annexin VI stimulates endocytosis and is involved in the trafficking of low density lipoprotein to the prelysosomal compartment | Q74162441 | ||
| Predicting fibrosis worsening in obese patients with NASH through parenchymal fibronectin, HOMA-IR, and hypertension | Q84794899 | ||
| P433 | issue | 1-2 | |
| P304 | page(s) | 81-90 | |
| P577 | publication date | 2016-06-23 | |
| P1433 | published in | Molecular and Cellular Biochemistry | Q1573176 |
| P1476 | title | Annexin A6 protein is downregulated in human hepatocellular carcinoma | |
| P478 | volume | 418 |
| Q58778932 | Altered hepatic glucose homeostasis in AnxA6-KO mice fed a high-fat diet |
| Q90321260 | Annexin A6 is critical to maintain glucose homeostasis and survival during liver regeneration |
| Q92130001 | Annexins in Adipose Tissue: Novel Players in Obesity |
| Q93004356 | Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside |
| Q50951548 | Chemokine (CC-motif) receptor-like 2 mRNA is expressed in hepatic stellate cells and is positively associated with characteristics of non-alcoholic steatohepatitis in mice and men. |
| Q91739105 | Expression levels and prognostic values of annexins in liver cancer |
| Q38734992 | Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis |
| Q95265722 | Identification of Prognostic Immune Genes in Bladder Urothelial Carcinoma |
| Q61806373 | Implication of calcium activated RasGRF2 in Annexin A6-mediated breast tumor cell growth and motility |
| Q50888141 | Role of hepatic Annexin A6 in fatty acid-induced lipid droplet formation. |
| Q47754758 | The adaptor protein alpha-syntrophin is reduced in human non-alcoholic steatohepatitis but is unchanged in hepatocellular carcinoma |
Search more.